Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents

Antibiotic resistance threatens effective treatment of microbial infections globally. This situation has spurred the hunt for new antimicrobial compounds in both academia and the pharmaceutical industry. Here, we report how the widely used antitumor drug cisplatin may be repurposed as an effective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Mingjun, Chua, Song Lin, Liu, Yang, Drautz-Moses, Daniela I, Yam, Joey Kuok Hoong, Aung, Thet Tun, Beuerman, Roger W, Salido, May Margarette Santillan, Schuster, Stephan C, Tan, Choon-Hong, Givskov, Michael, Yang, Liang, Nielsen, Thomas E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2018
Materias:
Full Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296412/
https://www.ncbi.nlm.nih.gov/pubmed/30591828
http://dx.doi.org/10.3762/bjoc.14.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296412/
https://www.ncbi.nlm.nih.gov/pubmed/30591828
http://dx.doi.org/10.3762/bjoc.14.284

Ejemplares similares